Active

MACKS

Switched

BE0818679604

Rechtspersoon Private limited company 1 establishment

Beversebaan 38, 2070 Beveren-Kruibeke-Zwijndrecht Activiteiten van medische beeldvorming en medische laboratoria

Active for

16 year, 11 months

Financials

Financial year 2025

Gross margin

€ 396,213

▼ 31% vs 2024

Profit

Healthy

€ 308,286

▼ 26% vs 2024

Debts

Low

€ 453,828

▲ 1% vs 2024

MACKS from Beveren-Kruibeke-Zwijndrecht, company number BE0818679604, closed financial year 2025 with a result of € 308,286 after tax. For that financial year MACKS recorded a gross margin of € 396,213 and equity of € 2.2 million. Compared with financial year 2024, the result moved from € 418,432 to € 308,286. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What happened at MACKS?

What happened at MACKS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 308,286 (▼ 26% vs 2024). Source: NBB ↗
  • New establishment in Antwerpen. KBO
  • Start of the company according to the CBE. KBO
  • Katinka Schatteman became a director. NBB

In short

From € 307,873 profit in 2021 to € 308,286 profit in 2025.

Paid € 791,866 in corporate taxes since 2021.

Best year ever: 2022, with € 501,301 profit.

Paid out € 632,500 in dividends to the owners in total.

A new publication or filing at MACKS? We notify you, reason included.

Follow MACKS

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Katinka Schatteman

Behind MACKS is Katinka Schatteman. Katinka Schatteman is also behind Klinisch Biologen ZAS.

See the full network in the app

Directors

According to the 2025 annual accounts

Katinka Schatteman

Director

Also active at: Klinisch Biologen ZAS

since 2009

Establishments

Establishment units

Physical locations of this company

Registered office

Beversebaan 38

2070 Beveren-Kruibeke-Zwijndrecht

2.362.179.137

Lindendreef 1

2020 Antwerpen

Active since 18 September 2009

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0818.679.604
VAT number
BE 0818.679.604
Registered office
Beversebaan 38, 2070 Beveren-Kruibeke-Zwijndrecht
Names & denominations
MACKS
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
18 September 2009
Peppol
Active · Active since 17 Dec 2025
Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

Frequently asked questions

What is the enterprise number of MACKS?
The enterprise number of MACKS is BE0818679604.
What is the address of MACKS?
The registered office of MACKS is located at Beversebaan 38, 2070 Beveren-Kruibeke-Zwijndrecht.
When was MACKS founded?
MACKS was founded on 18 September 2009.
What is the main activity of MACKS?
The main activity of MACKS is "Activiteiten van medische beeldvorming en medische laboratoria" (NACE code 86910).
Does MACKS have a website?
No website is currently known for MACKS.
How much profit did MACKS make in 2025?
MACKS posted a profit after taxes of € 308,286 in financial year 2025.
What is the revenue of MACKS?
As a small company, MACKS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 396,213.
Where can I find the annual accounts of MACKS?
MACKS files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of MACKS?
According to the 2025 annual accounts, the directors of MACKS are: Katinka Schatteman.
Who owns MACKS?
Behind MACKS is Katinka Schatteman. Katinka Schatteman is also behind Klinisch Biologen ZAS.